The following is a reconciliation of the weighted average shares outstanding used to compute basic and diluted net income per common share:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Basic weighted average common shares outstanding		36,085,624		35,467,707		35,916,406		35,398,738
Effect of dilutive securities - equity compensation awards		812,865		797,173		801,025		552,570
Diluted weighted average common shares outstanding		36,898,489		36,264,880		36,717,431		35,951,308

Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Anti-dilutive equity instruments of 249,287 and 451,657 were excluded from the diluted weighted average common shares outstanding for the three months ended September 30, 2026 and 2025, respectively. Anti-dilutive equity instruments of 406,264 and 922,786 were excluded from the diluted weighted average common shares outstanding for the nine months ended September 30, 2026 and 2025, respectively.

No cash dividends were declared or paid during the three and nine months ended September 30, 2026 and 2025.